From July -22 Cerona Therapeutics will supply floxuridine through Cardinal Health Specialty Pharmaceutical Services (Cardinal SPS). Our previous supplier HIKMA Pharmaceuticals will no longer be producing floxuridine. The transition from HIKMA to Cerona Pharmaceutical Services will not have any impact on the Excalibur-trials.
